Q&A: Professor Maurice Moloney by Theodoulou, F. L.
Patron:		Her	Majesty	The	Queen	 	 Rothamsted	Research	
Harpenden,	Herts,	AL5	2JQ	
	
Telephone:	+44	(0)1582	763133	
Web:	http://www.rothamsted.ac.uk/	
	
	 	
	
	
Rothamsted Research is a Company Limited by Guarantee 
Registered Office: as above.  Registered in England No. 2393175. 
Registered Charity No. 802038.  VAT No. 197 4201 51. 
Founded in 1843 by John Bennet Lawes.	
	
Rothamsted Repository Download
G - Articles in popular magazines and other technical publications
Theodoulou, F. L. 2010. Q&A: Professor Maurice Moloney. Portland 
Press Ltd. doi:10.1042/BIO03203039 
The publisher's version can be accessed at:
• https://dx.doi.org/10.1042/BIO03203039
The output can be accessed at: https://repository.rothamsted.ac.uk/item/96z41/q-a-
professor-maurice-moloney.
© 1 June 2010, Portland Press Ltd.
25/11/2019 15:10 repository.rothamsted.ac.uk library@rothamsted.ac.uk
39
RegularsQ & A
June 2010 © 2010 The Biochemical Society
Q&A
Professor Maurice Moloney is the new director and chief 
executive of Rothamsted Research. He has written more than 
80 scientific papers and holds more than 300 patents in plant 
biotechnology worldwide. Professor Moloney is also a leading 
authority on plant cell biology, especially seed biology and its 
biotechnological applications in crop improvement. He is the 
12th director of Rothamsted since 1843, succeeding Professor 
Ian Crute CBE, who retired from the institute in 2009.
What do you consider to be your best 
research achievements?
An early example: at ICI, while I was still 
a teenager, we devised a number of new 
compounds that had very unusual effects on 
plant growth. In more recent years, the major 
thing that I’m known for is creating the first 
genetically modified crop plant (oilseed rape) at 
Calgene. We were competing with Monsanto: 
they transformed model plants – tobacco and 
petunia, but we were the first to transform real 
crops – oilseed rape and also tomato. You had a 
large company competing with a small company 
– David and Goliath, you might say! The impact 
on agriculture of developing the transforma-
tion systems has been enormous: for example, 
transgenic oilseed rape (canola) occupies 90 % 
of the acreage in Canada. That technology was 
immediately adopted by producers in Canada 
because it had such an impact on both yield 
and soil quality. And then, more recently, I 
have always looked upon a plant as simply a 
machine for converting carbon dioxide, water 
and nutrients into other chemicals, so with 
advent of genetic engineering, it’s been possible 
to reprogramme a plant to make it a factory and 
I’ve been involved in the production of protein 
pharmaceuticals. We’ve gone as far as perform-
ing human clinical trials with plant-made 
insulin, which was a world first. Plants are just 
as good as E. coli!
A logical progression from GM is synthetic 
biology; where do you stand on that?
Obviously, my track record in GM technology is 
How did you get into science?
In my family, science was always considered to be an important part of 
life. My parents weren’t scientists, but they always had a great respect for 
science. My dad worked in the aerospace industry and my mother worked 
in a cotton mill, but both of them always believed that our future was 
paved with the achievements of science and so there was an atmosphere 
of respect for science in the house. When my sister read chemistry at 
university and came back at weekends and told me all about what she was 
doing, it got me really excited and that’s how I ended up doing chemistry.
What makes you tick, scientifically? What gets you out of bed in  
the morning?
I have to be honest and say that virtually everything I’ve ever done in sci-
ence has been done with the motivation of some kind of application at the 
end of it all. I have never really got involved in science that is either purely 
theoretical or purely driven by curiosity. I’ve always investigated problems 
that, if you could solve, would actually make a difference through their 
application. Going back to my early career, I worked for ICI, developing 
plant growth regulators, using a lot of basic chemistry and that has been a 
paradigm for my scientific motivation. So I still get excited about the idea 
of coming to work and working on projects or helping people work on 
projects that have an economic or sociological or environmental benefit.
Thinking about this and the influence of your parents, do you think 
impact of research plays an important role in how scientists are 
perceived in society?
Yes. I think scientists have a responsibility to report back to the people who 
have provided money to do research. The vast majority of money comes 
from the general taxpayer. It’s hard, because what we have are specialists 
communicating with laypeople, and some people have more of a gift than 
others to get those messages from the lab back to the general public, but I 
think that it’s very important that we do that. If we find scientists that are 
particularly gifted in this way, then we should encourage them, because it 
is really the way that people understand that expenditures on science are 
true investments in our future.
Professor Maurice Moloney
Interviewed by Freddie Theodoulou (General Editor)
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writ large in the literature and so nobody would 
have any illusions… but seriously, as regards 
synthetic biology, I’m extremely interested in 
our ability though the successes of systems biol-
ogy to actually consider the idea of constructing 
organisms for specific purposes. Obviously, 
it will be a long time before we could create a 
synthetic plant or any eukaryote, but the oppor-
tunities for making synthetic micro-organisms 
or possibly synthetic organelles has not escaped 
most scientists. Things that sounded like Isaac 
Asimov science fiction a few years ago are now 
on our list of visions for the next 10 years.
What did you make of the anti-GM lobby’s 
response to your appointment?
The best headline that I saw was: “The BBSRC 
declares war on the natural food movement”! 
Nothing could be further from the truth: in 
matters of science, I’m a complete pacifist. We 
don’t need to engage in war, but we do need 
to be realistic. If there is a reason why BBSRC 
took a risk in placing a scientist who has a long 
history in GM in the Directorship of the one of 
the world’s great agricultural research institutes, 
it is because it is our long-term belief that we 
cannot solve the enormous problems that are 
on the horizon in agriculture, unless we use 
all the tools that are at our disposition. GM 
plants are not the only set of tools, but in order 
to do many of the things that we need to do in 
a timely manner, we will have to use whatever 
technologies enable us to get there fast enough. 
So my prediction is that the areas of response to 
climate change, bioenergy, food security, safety 
and quality, are going to have to enlist GM 
technologies as part of the future. These things 
take 5 to 10 years to move from the research 
base to commercialization and I think over 
this time period, we’ll see this debate becoming 
more rational and less politicized.
Why did you decide to take the job as 
Institute Director?
To be offered the chance to take charge of one of 
the top agricultural research institutes that has 
ever existed is a wonderful opportunity. It’s an 
offer that one could not refuse! 
What do you consider makes research 
institutes distinct from universities?
It’s a very important question, because a lot 
of people would think that the high quality of 
research that goes on in British universities 
should be sufficient. But we need to commit ourselves to many strategic 
objectives in order to change the way we do things in agriculture and 
those objectives require long-term commitment and they also require a 
high degree of inter- and trans-disciplinary collaboration. Those things 
are most efficiently done under one roof. Very often, you see institutes or 
centres being created at universities to realize the economies of scale and 
intellectual synergy that come with having people collaborate closely.
And how about the distinction between Rothamsted and the John 
Innes Centre?
First and foremost, I’m a great fan of the John Innes. The relationship that I 
fully intend to foster between Rothamsted and the JIC is one of collabora-
tion and complementation. One of the things that Rothamsted clearly 
needs to do, is to define itself and that definition will make it clear what 
we do that is distinct from the mandate of the JIC. We are entering into a 
strategic planning phase, but broadly, my view right now is that Rotham-
sted Research is perfectly placed to do incisive, translational, agricultural 
research and that can and will have just as much scientific impact as work-
ing on model systems. We’re going to be responsible for developing systems 
that can be transferred to the user sector, whether they be novel germplasm, 
novel agricultural chemicals or new systems for creating bioenergy. The 
responsibilities of the JIC are not necessarily to have to develop systems that 
are sufficiently robust to be transferred to the user sector. 
What do you think are the greatest challenges in the next few 
years? And the opportunities?
The immediate challenge is going to be ensuring financial sustainability 
of the Institute. This is not a problem that is unique to us; we have just 
emerged from a deep recession. We’re not going to be immune to financial 
hardship and yet we still have to deliver science. So, our main priority is 
balancing high-impact science that is useful with budgets that are going to 
be limited, at least for a few years. Having said that, hardships can also be 
opportunities to really focus on the things that we believe that we are very 
good at or that have a very high probability of making a large impact.
Will you conduct/direct your own research?
Yes. I’m very excited about the fact that a director can put a group together 
and continue to do active research. There are areas at Rothamsted in which 
we have a world-class reputation which happen to be very close to my 
interests, so I am in a fortunate position! The areas in which I am most 
likely to work are oilseed biochemistry and molecular biology. Also what 
you might call ‘bioproducts’: harnessing the power of plants to replace 
substrates that we normally obtain from fossil fuels.
Any other priorities?
I really want to focus on the combination of outreach and communication 
and the training of young scientists so that we can accelerate their careers 
by creating an appropriate working environment. To some extent, this 
is going to be dependent on funding. I would like to see an increase in 
public–private partnerships in this area, as we could become one of the 
foremost training grounds for the agribusiness community. If we are to 
meet some of the challenges of food production, bioenergy and climate 
change worldwide, there are going to be a lot of jobs for agricultural scien-
tists and we want to be one of the training grounds for those people. ■
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